IV TECHNOLOGIES PTE. LTD.
UEN: 201313409W
IV TECHNOLOGIES PTE. LTD.(201313409W) is a Singapore business with registered business address at 22 MALACCA STREET, 4-3, RB CAPITAL BUILDING, Singapore 48980. They specialise in the area of TELECOMMUNICATIONS RESELLERS/THIRD PARTY TELECOMMUNICATIONS PROVIDERS (INCLUDING VALUE-ADDED NETWORK OPERATORS) and WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT.
| Company Name | IV TECHNOLOGIES PTE. LTD. |
| Unique Entity Number | 201313409W |
| Entity Type | Local Company |
| Entity Status | Live Company |
| Incorporate Day | 17 May 2013 |
| Address |
22 MALACCA STREET #4-3 RB CAPITAL BUILDING Singapore 48980 |
| Products / Services |
TELECOMMUNICATIONS RESELLERS/THIRD PARTY TELECOMMUNICATIONS PROVIDERS (INCLUDING VALUE-ADDED NETWORK OPERATORS) WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT |
| Number of Officers | 3 |
| Paid Up Capital | SGD 100 |
Breaking! Business News
CargoChain Partners with FileVision on VaxTracks—Visibility Tracker for the COVID-19 VaccinesCargoChain Partners with FileVision on VaxTracks—Visibility Tracker for the COVID-19 VaccinesAvail...
Read More
CEO Dr. Johnson Lau Recuperating from COVID at HomeCEO Dr. Johnson Lau Recuperating from COVID at HomeGlobeNewswireJanuary 25, 2021BUFFALO, N.Y., Jan. ...
Read More
UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: PlitidepsinUCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Publishe...
Read More
Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloonFive-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .0...
Read More
Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and InnovationSamsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and ...
Read More
Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinicsPhilips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most ...
Read More
Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient carePhilips and Rennes University Hospital sign 5-year technology, research and innovation partnership t...
Read More
Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operations increases to EUR 608 million, Adjusted EBITA margin improves 110 bps to 19.0%, and operating cash flow increases to EUR 1,305 millionPhilips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operatio...
Read More